Novartis (NYSE-ADR:NVS) is based in Switzerland. It has a focus on cancer drugs and also owns Sandoz. It has a market cap of $223.8 bn, a price to earnings ratio of 31.12 and a dividend yield of 3.19per cent. Guest Nesan Nair, Sasfin Securities and resident expert Paul Theron from Vestact decide whether Novartis is hot or not.
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.